HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$46.47
Day range
$45.60 - $47.57
Year range
$20.08 - $57.28
Market cap
1.76B USD
Avg Volume
609.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 66.41M | 407.86% |
Operating expense | 69.03M | 60.52% |
Net income | -23.11M | 44.84% |
Net profit margin | -34.80 | 89.14% |
Earnings per share | -0.60 | 54.20% |
EBITDA | -23.99M | 45.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 291.38M | 28.11% |
Total assets | 376.99M | 42.00% |
Total liabilities | 152.46M | 122.56% |
Total equity | 224.53M | — |
Shares outstanding | 38.38M | — |
Price to book | 7.94 | — |
Return on assets | -16.21% | — |
Return on capital | -20.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.11M | 44.84% |
Cash from operations | -22.18M | 43.61% |
Cash from investing | -59.57M | -433.75% |
Cash from financing | 2.93M | -85.19% |
Net change in cash | -78.83M | -4,469.80% |
Free cash flow | -24.20M | 3.36% |
About
Founded
2016
Headquarters
Website
Employees
323
